Posts by: Patricia Silva PhD

Patricia Silva PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

November 11, 2015November 11, 2015

IBD Research to Advance with Boehringer Ingelheim New Partnerships

News

Boehringer Ingelheim recently announced a new collaboration with four leading U.S. scientific institutions to advance research and development of new therapeutic strategies for patients living with inflammatory bowel disease (IBD), ... Read more

November 10, 2015November 10, 2015

IBD Patients Benefit From Meditation, Exercise

News

A study recently published in the journal Inflammatory Bowel Diseases revealed that training in mindfulness-based techniques such as meditation can offer lasting improvements in the quality of life and mental ... Read more

November 5, 2015November 5, 2015

Theravance Biopharma Submits IBD Drug for FDA Investigational Approval

News

Theravance Biopharma, Inc., a company focused on underserved markets related to infectious diseases, lung and gastrointestinal tract disorders, recently announced in a press release the submission of an investigational new ... Read more

November 4, 2015November 4, 2015

Biomecite’s IBD Diagnostic Tool to Be Evaluated in Proof of Concept Study

News

Biomecite Diagnostics, LLC, a medical diagnostics company, recently announced that it is enrolling patients for a proof of concept study whose goal is to assess the accuracy of a new diagnostic ... Read more

October 27, 2015October 27, 2015

Ulcerative Colitis Celgene’s Therapy Ozanimod Shows Promising Results in Phase 2 Trial

News

Celgene Corporation, a biopharmaceutical company focused on the development of innovative therapies for cancer and immune-inflammatory related diseases, recently announced the results of the “maintenance phase” of its Phase 2 ... Read more

October 26, 2015October 27, 2015

Fecal Transplantation Shows Early Promise as a Therapy

News

A recent editorial article published in The BMJ journal by Professor Tim Spector from King’s College London in the United Kingdom and Professor Rob Knight from the University of California, ... Read more

October 6, 2015October 12, 2015

Bariatric Surgery Reported to Be Safe, Feasible and Effective in Obese IBD Patients

News

A new study recently published in the journal Obesity Surgery suggests that bariatric surgery is a safe, feasible and effective intervention in obese patients suffering from inflammatory bowel disease (IBD). ... Read more

October 1, 2015October 1, 2015

Researchers Offer New Insights into the Role of Tumor Necrosis Factor in IBD

IBD News, News

A study led by researchers at Children’s Hospital Los Angeles recently revealed new insights into the role of tumor necrosis factor in the development of inflammatory bowel disease (IBD). The ... Read more

September 18, 2015September 21, 2015

Fecal Microbiota Transplantation Shown To Be a Promising Therapeutic Strategy for Ulcerative Colitis

News, Ulcerative colitis

A study recently published in the Journal of Translational Medicine showed that fecal microbiota transplantation may represent a promising therapeutic approach for patients with ulcerative colitis. The study is entitled “Step-up ... Read more

September 15, 2015September 16, 2015

Early Combined Immunosuppression Treatment in Crohn’s Disease Found to Improve Disease Course

News

A new study recently published in the journal The Lancet revealed that early combined immunosuppression (ECI) treatment can improve the disease course in patients with Crohn’s disease. The study is ... Read more